MIRATRYP-100000 I.U. 1VIAL

About

Miratryp-100000 I.U. is a potent thrombolytic agent, typically containing an enzyme like urokinase or streptokinase, designed to dissolve existing blood clots. These enzymes act by converting plasminogen into plasmin, which is the primary enzyme responsible for breaking down fibrin, the main component of blood clots. By initiating fibrinolysis, Miratryp helps to restore blood flow in vessels obstructed by thrombi, preventing tissue damage and improving patient outcomes in acute thrombotic events.

It is primarily indicated for conditions where rapid clot dissolution is critical, such as pulmonary embolism, deep vein thrombosis, and certain arterial occlusions. The administration of this medication requires careful monitoring in a hospital setting due to its potent action and potential for severe bleeding complications, necessitating close medical supervision throughout the treatment period.

Uses

• Acute pulmonary embolism
• Deep vein thrombosis (DVT)
• Acute arterial thromboembolism
• Occluded intravenous catheters

Directions For Use

Administered intravenously by a healthcare professional in a hospital setting. Dosage and infusion rate are carefully calculated based on the patient's condition.

Benefits

• Dissolves existing blood clots rapidly
• Restores blood flow in occluded vessels
• Prevents tissue ischemia and damage
• Improves outcomes in acute thrombotic events
• Reduces risk of long-term complications from clots
• Life-saving in critical situations

Side Effects

• Bleeding (major and minor)
• Hypotension
• Allergic reactions (rash, fever, chills)
• Nausea
• Vomiting
• Headache
• Bradycardia
• Arrhythmias
• Reperfusion injury
• Hematoma at injection site
• Anaphylaxis (rare)
• Intracranial hemorrhage (serious, rare)

Safety Measures

• Alcohol - Not directly relevant to acute administration; however, alcohol can increase bleeding risk and should be avoided.
• Pregnancy - Contraindicated due to high risk of maternal and fetal bleeding; consult your doctor.
• Breastfeeding - Not recommended due to potential for adverse effects on the infant; consult your doctor.
• Liver - Use with extreme caution in severe liver disease due to increased bleeding risk; consult your physician.
• Kidney - Use with caution in severe kidney disease; dose adjustment may be necessary; consult your physician.
• Lung - Often used for pulmonary embolism; use with caution in patients with active lung bleeding or severe lung disease.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.